MIR595 (microRNA 595)

2017-04-01  

Identity

HGNC
MIR595
LOCATION
7q36.3
LOCUSID
693180
ALIAS
MIRN595,hsa-mir-595

Other Information

Locus ID:

NCBI: 693180
HGNC: 32851
Ensembl: ENSG00000207637
miRBase:

Variants:

dbSNP: 693180
ClinVar: 693180
TCGA: ENSG00000207637
COSMIC: MIR595

RNA/Proteins

PharmGKB

Entity IDNameTypeEvidenceAssociationPKPDPMIDs
PA446157Leukemia, B-Cell, AcuteDiseaseVariantAnnotationnot associated27649261
PA450428methotrexateChemicalVariantAnnotationnot associated27649261

References

Pubmed IDYearTitleCitations
256280402015Overexpression of miR-595 and miR-1246 in the sera of patients with active forms of inflammatory bowel disease.13
278934292016MicroRNA-595 sensitizes ovarian cancer cells to cisplatin by targeting ABCB1.13
271330482016MiR-595 targeting regulation of SOX7 expression promoted cell proliferation of human glioblastoma.11
261831582015Identification of ULK1 as a novel biomarker involved in miR-4487 and miR-595 regulation in neuroblastoma SH-SY5Y cell autophagy.10
273741042016RPL27A is a target of miR-595 and may contribute to the myelodysplastic phenotype through ribosomal dysgenesis.4
293450512018MiR-595 Suppresses the Cellular Uptake and Cytotoxic Effects of Methotrexate by Targeting SLC19A1 in CEM/C1 Cells.3
297375522018Competing endogenous RNA network crosstalk reveals novel molecular markers in colorectal cancer.3
290771702017Mir-595 is a significant indicator of poor patient prognosis in epithelial ovarian cancer.0

Citation

Dessen P

MIR595 (microRNA 595)

Atlas Genet Cytogenet Oncol Haematol. 2017-04-01

Online version: http://atlasgeneticsoncology.org/gene/56892/mir595